Jul 12, 2019   SOURCE: PR NewsWire

Non-Melanoma Skin Cancer Market in the United States to 2024: Pipeline; Epidemiology; Market Valuations; Drugs, Sales, and Market Share

DUBLIN, July 12, 2019 /PRNewswire/ -- The "US Non-Melanoma Skin Cancer Market and Competitive Landscape - 2019" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

US Non-Melanoma Skin Cancer Market and Competitive Landscape Highlights - 2019, provides comprehensive insights into Non-Melanoma Skin Cancer pipeline products, Non-Melanoma Skin Cancer epidemiology, Non-Melanoma Skin Cancer market valuations and forecast, Non-Melanoma Skin Cancer drugs sales and competitive landscape in the US.

The research is classified into seven sections - Non-Melanoma Skin Cancer treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.

Research Scope

    --  Non-Melanoma Skin Cancer pipeline: Find out the products in clinical
        trials for the treatment of Non-Melanoma Skin Cancer by development
        phase 3, phase 2, and phase 1, by pharmacological class and companies
        developing the products
    --  Non-Melanoma Skin Cancer epidemiology: Find out the number of patients
        diagnosed (prevalence) with Non-Melanoma Skin Cancer in the US
    --  Non-Melanoma Skin Cancer drugs: Identify key products marketed and
        prescribed for Non-Melanoma Skin Cancer in the US, including trade name,
        molecule name, and company
    --  Non-Melanoma Skin Cancer drugs sales: Find out the sales revenues of
        Non-Melanoma Skin Cancer drugs in the US
    --  Non-Melanoma Skin Cancer market valuations: Find out the market size for
        Non-Melanoma Skin Cancer drugs in 2018 in the US. Find out how the
        market advanced from 2014 and forecast to 2024
    --  Non-Melanoma Skin Cancer drugs market share: Find out the market shares
        for key Non-Melanoma Skin Cancer drugs in the US

Benefits of this Research

    --  Support monitoring and reporting national Non-Melanoma Skin Cancer
        market analysis and sales trends
    --  Track competitor drugs sales and market share in the US Non-Melanoma
        Skin Cancer market
    --  Track competitive developments in Non-Melanoma Skin Cancer market and
        present key issues and learnings
    --  Synthesize insights for Non-Melanoma Skin Cancer market and products to
        drive business performance
    --  Answer key business questions about the Non-Melanoma Skin Cancer market
    --  Evaluate commercial market opportunity assessment, positioning, and
        segmentation for Non-Melanoma Skin Cancer products
    --  Supports decision making in R&D to long term marketing strategies

Key Topics Covered
1) Non-Melanoma Skin Cancer Treatments
2) Non-Melanoma Skin Cancer Pipeline
3) US Non-Melanoma Skin Cancer Epidemiology
4) Marketed Drugs for Non-Melanoma Skin Cancer in US
5) US Non-Melanoma Skin Cancer Market Size and Forecast
6) US Non-Melanoma Skin Cancer Products Sales and Forecast
7) US Non-Melanoma Skin Cancer Market Competitive Landscape
8) Methodology

List of Tables
1. Non-Melanoma Skin Cancer Phase 3 Clinical Trials, 2019
2. Non-Melanoma Skin Cancer Phase 2 Clinical Trials, 2019
3. Non-Melanoma Skin Cancer Phase 1 Clinical Trials, 2019
4. Non-Melanoma Skin Cancer Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Non-Melanoma Skin Cancer, US, 2018
6. Non-Melanoma Skin Cancer Market Size and Forecast ($), US, 2014 - 2024
7. Non-Melanoma Skin Cancer Product Sales ($), US, 2014 - 2024

List of Figures
1. Non-Melanoma Skin Cancer Epidemiology, US, 2014 - 2024
2. Non-Melanoma Skin Cancer Market Size and Forecast ($), US, 2014 - 2024
3. Non-Melanoma Skin Cancer Products Market Share (%), US, 2018

For more information about this report visit https://www.researchandmarkets.com/r/9y4uft

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/non-melanoma-skin-cancer-market-in-the-united-states-to-2024-pipeline-epidemiology-market-valuations-drugs-sales-and-market-share-300883417.html

SOURCE Research and Markets